CytomX Therapeutics logo

CytomX Therapeutics

A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.

2

Funding Rounds

$71.0m

Money raised

Overview

A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.

Funding series

Funding Series Analysis

The company CytomX Therapeutics has raised a total of $30m in funding over 2 rounds.

Key Insights:

  • CytomX Therapeutics Series B round: $30m
  • CytomX Therapeutics Series B round August 2012: $41m
CytomX Therapeutics logo
CytomX Therapeutics Series B round $30m
CytomX Therapeutics logo
CytomX Therapeutics Series B round August 2012 $41m